Wynca plans to build a project of 3000t/a Glufosinate-ammonium TC and 2940t/a Glufosinate-ammonium AS

Recently, the environmental impact assessment documents of 6,000 t/a Glufosinate-ammonium technical and 20,000 t/a Methyldiethoxyphosphine phase I project were published on the website of Shizuishan. Ningxia Wynca, the holding subsidiary of Wynca, plans to invest ¥280.33 million in the construction of 3,000t/a Glufosinate-ammonium technical and 2940t/a Glufosinate-ammonium AS

Ningxia Wynca, located in Pingluo Industrial Park, formerly Ningxia Sanxi, was established in 2006. In 2010, the company was restructured into the holding subsidiary of Wynca and renamed as "Ningxia Wynca, mainly engaged in phosgene series products. The existing plant has a production capacity of 10,000t/a Phosgene (all for personal use but not for sale), 4,000t/a Diuron, 5,000t/a Carbendazim,10,000t/a Methyl chloroformate and 2,000t/a Chloromethyl carbonochloridate.

Among the above devices, due to the influence of the chemical industry market in recent years, Carbendazim device has been discontinued since 2016, and Chloromethyl carbonochloridate device has not been started since its construction. Currently, the stable operating devices are 10000t/a Phosgene (all for personal use but not for sale), 4000t/a Diuron and 10000t/a Methyl chloroformate. Ningxia Wynca recorded a total of 6 construction projects, of which 4 completed construction, 2 under constructio